NASDAQ:IOVA
Iovance Biotherapeutics, Inc.
- Stock
Last Close
10.43
17/05 20:00
Market Cap
1.94B
Beta: 0.20
Volume Today
4.45M
Avg: 3.51M
PE Ratio
−4.56
PFCF: −7.39
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.00 - | |||||||||||
cash conversion cycle | -204.32 - | |||||||||||
cash per share | 2.02 - | 1.80 10.80% | 4.36 142.74% | 4.09 6.18% | 2.23 45.56% | 4.82 116.15% | 2.47 48.72% | 4.55 84.28% | 3.29 27.75% | 2.96 9.89% | 1.19 59.83% | |
company equity multiplier | 1.13 - | 1.04 8.14% | 1.02 2.06% | 1.03 1.39% | 1.07 3.71% | 1.03 3.43% | 1.15 11.77% | 1.17 1.54% | 1.25 6.82% | 1.33 6.28% | 1.33 0.44% | |
days of inventory outstanding | 114.28 - | |||||||||||
days of payables outstanding | 32.38 - | 48.81 50.74% | 364.96 - | |||||||||
days of sales outstanding | 46.35 - | |||||||||||
dividend yield | 0.13 - | |||||||||||
ebit per revenue | -387.35 - | |||||||||||
ebt per ebit | 1.12 - | 1.00 10.84% | 0.99 0.67% | 0.99 0.68% | 0.99 0.52% | 0.96 2.80% | 0.95 0.89% | 0.99 3.77% | 1.00 0.77% | 0.99 0.62% | 0.97 2.10% | |
effective tax rate | -0.02 - | 0.04 - | 0.02 48.81% | 0.01 44.07% | -0.04 466.07% | 0.05 240.21% | 0.01 82.90% | 0.04 364.57% | 0.02 64.24% | 0.01 48.45% | ||
enterprise value multiple | -3.66 - | -12.69 246.87% | -8.58 32.38% | -4.06 52.73% | -4.05 0.08% | -6.07 49.76% | -16.62 173.80% | -24.55 47.65% | -8.53 65.27% | -2.18 74.41% | -4.38 100.77% | |
fixed asset turnover | 0.01 - | |||||||||||
free cash flow per share | -0.38 - | -0.41 8.72% | -0.44 7.43% | -0.62 40.71% | -1.22 97.57% | -1.05 13.83% | -1.33 26.62% | -1.82 36.60% | -1.73 4.98% | -1.97 13.62% | -1.63 16.93% | |
gross profit margin | -26.86 - | |||||||||||
interest coverage | -50.91 - | -2.13K 4,078.57% | -139.30 93.45% | -133.63 - | ||||||||
inventory turnover | 3.19 - | |||||||||||
long term debt to capitalization | 0.01 - | 0.06 361.46% | 0.10 49.42% | 0.14 49.67% | 0.00 98.82% | |||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.95 5.31% | 0.99 4.65% | 0.96 3.34% | 0.98 2.83% | 0.99 0.74% | |
net profit margin | -373.45 - | |||||||||||
operating cash flow per share | -0.38 - | -0.35 7.89% | -0.41 19.79% | -0.59 42.81% | -1.21 104.10% | -1.04 13.73% | -1.28 22.78% | -1.48 16.07% | -1.49 0.18% | -1.84 23.72% | -1.54 16.29% | |
operating cycle | 160.63 - | |||||||||||
operating profit margin | -387.35 - | |||||||||||
payables turnover | 11.27 - | 7.48 33.66% | 1.00 - | |||||||||
pretax profit margin | -376.38 - | |||||||||||
price fair value | 5.82 - | 4.38 24.70% | 3.30 24.84% | 2.30 30.18% | 3.59 55.90% | 1.85 48.53% | 11.51 523.37% | 9.77 15.09% | 4.71 51.81% | 2.04 56.76% | 3.27 60.54% | |
receivables turnover | 7.87 - | |||||||||||
return on assets | -1.28 - | -0.26 79.74% | -0.26 1.17% | -0.31 17.54% | -0.59 92.55% | -0.26 56.62% | -0.54 111.18% | -0.33 38.33% | -0.42 25.99% | -0.59 39.25% | -0.57 3.10% | |
return on capital employed | -1.29 - | -0.27 79.12% | -0.27 0.25% | -0.32 19.98% | -0.64 98.67% | -0.27 56.93% | -0.68 146.20% | -0.37 45.78% | -0.50 35.67% | -0.70 39.90% | -0.69 1.35% | |
return on equity | -1.44 - | -0.27 81.39% | -0.27 0.92% | -0.32 19.17% | -0.63 99.70% | -0.27 58.11% | -0.63 136.05% | -0.39 37.38% | -0.53 34.59% | -0.78 47.99% | -0.76 2.67% | |
total debt to capitalization | 0.04 - | 0.07 96.94% | 0.10 41.46% | 0.16 57.60% | 0.01 90.90% |
All numbers in USD (except ratios and percentages)